# A Study to Compare Pharmacokinetics and Pharmacodynamics of GP-40081 to NovoMix® 30 Penfill® in Healthy Subjects

> **NCT04184492** · NA · COMPLETED · sponsor: **Geropharm** · enrollment: 34 (actual)

## Conditions studied

- Clamp Study

## Interventions

- **DRUG:** GP-40081
- **DRUG:** NovoMix® 30 Penfill®

## Key facts

- **NCT ID:** NCT04184492
- **Lead sponsor:** Geropharm
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-15
- **Primary completion:** 2019-06-28
- **Final completion:** 2019-06-28
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2019-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04184492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04184492, "A Study to Compare Pharmacokinetics and Pharmacodynamics of GP-40081 to NovoMix® 30 Penfill® in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04184492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*